Yingli Ma
Known title: CHIEF TECHNOLOGY OFFICERCIK: 0001963664
Associated companies
Transaction History
| GPCR | ▲ Buy | Grant | 32,526 | $0 | 3/19/2026 | View on chart |
| GPCR | ▼ Sell | Tax Withholding | 11,313 | $237K | 3/3/2026 | View on chart |
| GPCR | ▼ Sell | Tax Withholding | 4,470 | $31K | 7/1/2025 | View on chart |
| GPCR | ▲ Buy | Grant | 24,459 | $0 | 7/1/2025 | View on chart |
| GPCR | ▲ Buy | Grant | 63,810 | $0 | 3/15/2025 | View on chart |
| GPCR | ▼ Sell | Tax Withholding | 1,824 | $14K | 3/1/2025 | View on chart |
| GPCR | ▲ Buy | Grant | 36,729 | $0 | 3/15/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
LLY Stock Dip News Unrelated to GPCR
Recent headlines focus on Eli Lilly (LLY) stock performance, which does not provide specific news about Structure Therapeutics (GPCR). While GPCR technical indicators show extreme oversold conditions, the provided news articles do not contain company-specific updates or developments for this symbol.
LLY Stock Dip News Unrelated to GPCR. Recent headlines focus on Eli Lilly (LLY) stock performance, which does not provide specific news about Structure Therapeutics (GPCR). While GPCR technical indicators show extreme oversold conditions, the provided news articles do not contain company-specific updates or developments for this symbol.